课题基金 / 基金详情

EFFICACY OF PROPIONYL L CARNITINE IN EXERCISE LIMITING CLAUDICATION

EFFICACY OF PROPIONYL L CARNITINE IN EXERCISE LIMITING CLAUDICATION
丙酰左旋肉碱对运动限制性跛行的疗效
批准号：
3742334
负责人：
JOHN M. PORTER
金额：
$0.0万
依托单位：
OREGON HEALTH & SCIENCE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3742334
关键词：
carnitine clinical trials dosage drug screening /evaluation exercise human subject human therapy evaluation limb movement longitudinal human study neuromuscular disorder neuromuscular disorder chemotherapy oral administration

项目摘要

项目成果

JOHN M. PORTER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This trial involves 300 patients from 15 centers (20 patients per site) and is a placebo-controlled, dose-ranging, randomized study aimed at investigating both safety and efficacy of three different doses of oral propionly l-carnitine hydrochloride (PLC-HCL) in patients with intermittent claudication. Efficacy will be assessed by evaluating maximal walking distance on a standardized treadmill after six months of double-blind treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CHRONIC ADMINISTRATION OF CILOSTAZOL IN PATIENTS WITH INTERMITTENT CLAUDICATION
SAFETY AND EFFICACY OF IV LIPO PGE1 THERAPY IN PATIENTS WITH ISCHEMIC ULCERS
NATURAL HISTORY OF RAYNAUD'S SYNDROME
CHRONIC ADMINISTRATION OF CILOSTAZOL IN PATIENTS WITH INTERMITTENT CLAUDICATION
海外基金